In this session, Dr. Neil Thakur and Dr. Kuldip Dave from the ALS Association discuss the implications of the CENTAUR trial for the ALS community.
The views and opinions expressed in this webinar do not necessarily reflect the position of NEALS, the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital, or Amylyx.
